ARTICLE | Company News
Amorfix, JSW Lifesciences GmbH deal
January 16, 2012 8:00 AM UTC
CRO JSW Lifesciences signed a letter of intent for an exclusive, worldwide license to use Amorfix's Amorfix Aggregated Abeta Assay (A4) for preclinical research in Alzheimer's disease (AD). Amorfix wo...